2024

• Flygt, Hjalmar; Söderlund, Stina; Richter, Johan; Saussele, Susanne; Koskenvesa, Perttu; Stenke, Leif. (2024) Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 10.1038/s41375-024-02145-6). Leukemia
  Errata
• Flygt, Hjalmar; Söderlund, Stina; Richter, Johan; Saussele, Susanne; Koskenvesa, Perttu; Stenke, Leif. (2024) Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial. Leukemia
  Vitenskapelig artikkel
• Mahon, Francois-Xavier; Pfirrmann, Markus; Dulucq, Stéphanie; Hochhaus, Andreas; Panayiotidis, Panayiotis; Almeida, Antonio. (2024) European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission. Journal of Clinical Oncology
  Vitenskapelig artikkel
• Gambacorti-Passerini, Carlo; Brümmendorf, Tim H.; Abruzzese, Elisabetta; Kelly, Kevin R.; Oehler, Vivian G.; García-Gutiérrez, Valentín. (2024) Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial. Leukemia
  Vitenskapelig artikkel
• Efficace, Fabio; Mahon, Francois-Xavier; Richter, Johan; Piciocchi, Alfonso; Cipriani, Marta; Nicolini, Franck E.. (2024) Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial. Leukemia
  Vitenskapelig artikkel

2023

• Geelen, Inge G.P.; Gullaksen, Stein-Erik; Ilander, Mette M.; Olssen-Strömberg, Ulla; Mustjoki, Satu; Richter, Johan. (2023) Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. Annals of Hematology
  Vitenskapelig artikkel
• Behsen, Alenka Djarmila; Vandsemb, Esten Nymoen; Slørdahl, Tobias Schmidt; Hjorth-Hansen, Henrik; Quist-Paulsen, Petter; Misund, Kristine. (2023) A patient with minimal myeloma treatment who survived for 20 years. Haematologica
  Vitenskapelig artikkel
• Machova Polakova, Katerina; Albeer, Ali; Polivkova, Vaclava; Krutska, Monika; Vlcanova, Katerina; Curik, Nikola. (2023) The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia
  Vitenskapelig artikkel
• Huuhtanen, Jani; Adnan-Awad, Shady; Theodoropoulos, Jason; Forstén, Sofia; Warfvinge, Rebecca; Dufva, Olli. (2023) Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation. Leukemia
  Vitenskapelig artikkel

2022

• Huuhtanen, Jani; Ilander, Mette; Yadav, Bhagwan; Dufva, Olli M.J.; Lähteenmäki, Hanna; Kasanen, Tiina. (2022) IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia. Journal of Clinical Investigation
  Vitenskapelig artikkel

2021

• Flygt, Hjalmar; Söderlund, Stina; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu; Mustjoki, Satu. (2021) Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study. European Journal of Haematology
  Vitenskapelig artikkel
• Richter, Johan; Lübking, Anna; Söderlund, Stina; Lotfi, Kourosh; Markevärn, Berit; Själander, Anders. (2021) Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI. Leukemia
  Vitenskapelig artikkel

2020

• Hochhaus, Andreas; Baccarani, Michele; Silver, Richard T.; Schiffer, Charles A.; Apperley, Jane F.; Cervantes, Francisco. (2020) European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia
  Vitenskapelig oversiktsartikkel/review
• Söderlund, Stina; Persson, Inger; Ilander, Mette; Guilhot, Joelle; Hjorth-Hansen, Henrik; Koskenvesa, Perttu. (2020) Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy. Leukemia Research
  Vitenskapelig artikkel
• Berentsen, Sigbjørn; Barcellini, Wilma; D'Sa, Shirley; Randen, Ulla; Tvedt, Tor Henrik Anderson; Fattizzo, Bruno. (2020) Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood
  Vitenskapelig artikkel
• Rio-Machin, Ana; Villiamy, Tom; Hug, Nele; Walne, Amanda; Tawana, Kiran; Cardoso, Shirleny. (2020) The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants. Nature Communications
  Vitenskapelig artikkel

2019

• Kreutzman, Anna; Yadav, Bhagwan; Brümmendorf, Tim H.; Gjertsen, Bjørn Tore; Lee, Moon Hee; Janssen, Jeroen. (2019) Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. Oncoimmunology
  Vitenskapelig artikkel
• Hjorth-Hansen, Henrik. (2019) TKI safety. HemaSphere
  Vitenskapelig artikkel

2018

• Bouillon, Anne-Sophie; Ventura Ferreira, Monica S.; Awad, Shady Adnan; Richter, Johan; Hochhaus, Andreas; Kunzmann, Volker. (2018) Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia. Blood Advances
  Vitenskapelig artikkel
• Landberg, Niklas; von Palffy, Sophia; Askmyr, Maria K.; Lilljebjorn, Henrik; Sanden, Carl; Rissler, Marianne. (2018) CD36 Defines Primitive Chronic Myeloid Leukemia Cells Less Responsive To Imatinib But Vulnerable To Antibody-Based Therapeutic Targeting. Haematologica
  Vitenskapelig artikkel
• Saussele, Susanne; Richter, Johan; Guilhot, Joelle; Gruber, Franz; Hjorth-Hansen, Henrik; Almeida, Antonio. (2018) Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial. The Lancet Oncology
  Vitenskapelig artikkel

2017

• Pietarinen, Paavo O; Eide, Christopher A; Ayuda-Duran, Maria del Pilar; Potdar, Swapnil; Kuusanmäki, Heikki; Andersson, Emma I. (2017) Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors. OncoTarget
  Vitenskapelig artikkel
• Gullaksen, Stein-Erik; Skavland, Jørn; Gavasso, Sonia; Tosevski, Vinko; Warzocha, Krzysztof; Dumrese, Claudia. (2017) Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib. Haematologica
  Vitenskapelig artikkel
• Ilander, Mette; Olsson-Strömberg, Ulla; Schlums, Heinrich; Guilhot, Joëlle; Brück, Oscar; Lähteenmäki, Hanna. (2017) Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia. Leukemia
  Vitenskapelig artikkel
• Hochhaus, Andreas; Saussele, Susanne; Rosti, Gianantonio; Mahon, François-Xavier; Janssen, Jeroen J.W.M.; Hjorth-Hansen, Henrik. (2017) Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology
  Vitenskapelig artikkel
• Warfvinge, Rebecca; Geironson, Linda; Sommarin, Mikael NE; Lang, Stefan; Karlsson, Christine; Roschupkina, Teona. (2017) Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML. Blood
  Vitenskapelig artikkel
• Rajala, Hanna L.M.; El Missiry, Mohamed; Ruusila, Anniina; Koskenvesa, Perttu; Brümmendorf, Tim H.; Gjertsen, Bjørn Tore. (2017) Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology
  Vitenskapelig artikkel
• Müller, Martin C.; Cervantes, Francisco; Hjorth-Hansen, Henrik; Janssen, Jeroen J.W.M.; Milojkovic, Dragana; Rea, Delphine. (2017) Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel. Critical Reviews in Oncology/Hematology
  Vitenskapelig oversiktsartikkel/review
• El Missiry, Mohamed; Hjorth-Hansen, Henrik; Richter, Johan; Olson-Strömberg, Ulla; Stenke, Leif; Porkka, Kimmo. (2017) Early BCR-ABL1 transcript decline after 1 month of tyrosine kinase inhibitor therapy as an indicator for treatment response in chronic myeloid leukemia. PLOS ONE
  Vitenskapelig artikkel

2016

• Hjorth-Hansen, Henrik; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu; Höglund, Martin; Dreimane, Arta. (2016) Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients. Leukemia
  Vitenskapelig artikkel
• Landberg, Niklas; Hansen, Nils Jakob Vest; Askmyr, Maria K.; Ågerstam, Helena; Lassen, Carin F.; Rissler, Marianne. (2016) IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome. Leukemia
  Brev til redaktøren
• El Missiry, Mohamed; Adnan Awad, Shady; Rajala, Hanna L.; Al-Samadi, Ahmed; Ekblom, Marja; Markevän, Berit. (2016) Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia. Journal of Cancer Research and Clinical Oncology
  Vitenskapelig artikkel
• Stray-Pedersen, Asbjørg; Sorte, Hanne Sørmo; Samarakoon, Pubudu Saneth; Gambin, Tomasz; Chinn, Ivan K.; Akdemir, Zeynep H.C.. (2016) Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders. Journal of Allergy and Clinical Immunology
  Vitenskapelig artikkel
• Söderlund, Stina; Christiansson, Lisa; Persson, Inger; Hjorth-Hansen, Henrik; Richter, Johan; Simonsson, Bengt. (2016) Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. Leukemia Research
  Vitenskapelig artikkel

2015

• Christiansson, Lisa; Söderlund, Stina; Mangsbo, Sara; Hjorth-Hansen, Henrik; Höglund, Martin; Markevärn, Berit. (2015) The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses. Molecular Cancer Therapeutics
  Vitenskapelig oversiktsartikkel/review
• Espinosa, Aurora; Hjorth-Hansen, Henrik; Aasly, Karin; Teigum, Ingvild; Sivertsen, Guro Hustad; Seghatchian, Jerard. (2015) Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: Some methodological aspects and clinical considerations. Transfusion and Apheresis Science
  Vitenskapelig oversiktsartikkel/review
• Hjorth-Hansen, Henrik; Stenke, Leif; Söderlund, Stina; Dreimane, Arta; Ehrencrona, Hans; Gedde-Dahl, Thobias. (2015) Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: Clinical results from a randomised phase-2 study (NordCML006). European Journal of Haematology
  Vitenskapelig artikkel

2014

• Koskenvesa, P; Kreutzman, Anna; Rohon, P; Pihlman, M; Vakkila, Emmi; Rasanen, Anu. (2014) Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response. European Journal of Haematology
  Vitenskapelig artikkel

2013

• Fossmark, Reidar; Skarsvåg, Espen Christoffer; Aarset, Harald; Hjort-Hansen, Henrik; Waldum, Helge. (2013) Symptomatic primary (Al) amyloidosis of the stomach and duodenum. Case Reports in Gastrointestinal Medicine
  Vitenskapelig artikkel
• Skarsvåg, Espen Christoffer; Hjort-Hansen, Henrik; Fossmark, Reidar. (2013) Symptomatic primary (AL) amyloidosis in the stomach and duodenum. BestPractice Gastroenterologi
  Fagartikkel
• Baccarani, Michele; Deininger, MW; Rosti, Gianantonio; Hochhaus, Andreas; Soverini, Simona; Apperley, J.F.. (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood
  Vitenskapelig oversiktsartikkel/review
• Hjort-Hansen, Henrik; Abboud, Camille; Abdel-Rahman, Fawzi; Abruzzese, Elizabetta; Aguayo, Alvaro; Aljurf, Mahmoud Deeb Saeed. (2013) Price of drugs for chronic myeloid leukemia (CML), reflection of the unsustainable cancer drug prices: perspective of CML Experts. Blood
  Vitenskapelig oversiktsartikkel/review
• Mustjoki, Satu; Richter, Johan; Barbany, Gisela; Ehrencrona, Hans; Fioretos, Thoas; Gedde-Dahl, Thobias. (2013) Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients. Leukemia
  Vitenskapelig artikkel

2012

• Jönsson, Sofia; Hjorth-Hansen, Henrik; Olsson, Bob; Wadenvik, H; Sundan, Anders; Standal, Therese. (2012) Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro. Journal of Bone and Mineral Metabolism
  Vitenskapelig artikkel
• Gruber, Franz; Lundan, Tuija; Goll, Rasmus; Silye, Aleksandra; Mikkola, Ingvild; Rekvig, Ole Petter. (2012) BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?. Medical Oncology (MO)
  Vitenskapelig artikkel
• Kreutzman, Anna; Jaatinen, Taina; Greco, D; Vakkila, Emmi; Richter, J; Ekblom, Marja. (2012) Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia. Experimental Hematology
  Vitenskapelig artikkel

2011

• Simonsson, B; Gedde-Dahl, Tobias; Markevärn, B; Remes, Kari; Stentoft, Jesper; Almqvist, Anders. (2011) Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia. Blood
  Vitenskapelig artikkel
• Simonsson, B; Hjorth-Hansen, Henrik; Bjerrum, Ole W; Porkka, K. (2011) Interferon alpha for Treatment of Chronic Myeloid Leukemia. Current Drug Targets
  Vitenskapelig oversiktsartikkel/review
• Koskela, Hanna; Strømberg, Anniina; Richter, Johan; Hjorth-Hansen, Henrik; Porkka, Kimmo; Mustjoki, Satu. (2011) Tyrosine Kinase Inhibitor Therapy Induced Changes in Humoral Immunity in Patients with Chronic Myeloid Leukemia. Blood
  Sammendrag/abstract

2010

• Jönsson, S; Hjorth-Hansen, Henrik; Olsson, B; Wadenvik, H; Sundan, Anders; Standal, Therese. (2010) Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitro. Leukemia
  Leserinnlegg
• Gimsing, Peter; Carlson, Kristina; Turesson, Ingemar; Fayers, Peter; Waage, Anders; Vangsted, Annette. (2010) Effect of pamidronate 30mg versus 90mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial. The Lancet Oncology
  Vitenskapelig artikkel
• Berentsen, Sigbjørn; Randen, Ulla; Vågan, Anna Marita; Hjort-Hansen, Henrik; Vik, Anders; Dalgaard, Jakob. (2010) High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. Blood
  Vitenskapelig artikkel
• Simonsson, Bengt; Gedde-Dahl, Thobias; Markevärn, Berit; Remes, Kari; Stentoft, Jesper; Almqvist, Anders. (2010) MAJOR MOLECULAR RESPONSE RATE AT ONE YEAR IS HIGHER IF PEGYLATED INTERFERON ALPHA-2B IS ADDED TO IMATINIB IN NON-HR CHRONIC MYELOID LEUKEMIA PATIENTS IN IMATINIB INDUCED COMPLETE HEMATOLOGICAL REMISSION. Haematologica
  Sammendrag/abstract

2009

• Reseland, Janne Elin; Reppe, Sjur; Olstad, Ole Kristoffer; Hjorth-Hansen, Henrik; Brenne, Anne-Tove; Syversen, Unni. (2009) Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma. European Journal of Haematology
  Vitenskapelig artikkel
• Mustjoki, Satu; Ekblom, M; Arstila, TP; Dybedal, I; Epling-Burnette, PK; Guilhot, F. (2009) Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia
  Vitenskapelig artikkel
• Baccarani, Michele; Rosti, Gianantonio; Castagnetti, Fausto; Haznedaroglu, Ibrahim; Porkka, Kimmo; Abruzzese, Elisabetta. (2009) Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study. Blood
  Vitenskapelig artikkel
• Hjorth-Hansen, Henrik; Gruber, Franz. (2009) Towards a quantitative understanding of CML resistance – selective and de-selective processes upon treatment with tyrosine kinase inhibitors and their clinical interpretation. Franz Gruber selv
  Doktorgradsavhandling
• Vefring, HK; Gruber, Franz; Wee, L; Hovland, R; Hjorth-Hansen, H; Dahl, TG. (2009) Chronic Myelogenous Leukemia with the e6a2 BCR-ABL and Lacking Imatinib Response: Presentation of Two Cases. Acta Haematologica
  Vitenskapelig artikkel
• Simonsson, Bengt; Gedde-Dahl, Thobias; Markevarn, B; Remes, Kari; Stentoft, J; Almqvist, Anders. (2009) A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy. Blood
  Sammendrag/abstract

2008

• Porkka, Kimmo; Koskenvesa, Perttu; Lundan, Tuija; Rimpilaeinen, Johanna; Mustjoki, Satu; Smykla, Richard. (2008) Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood
  Vitenskapelig artikkel

2007

• Koskenvesa, P; Rimpilainen, J; Lundan, T; Mustjoki, S; Brethon, B; Hjorth-Hansen, H. (2007) Dasatinib is an effective treatment of central nervous system Ph-positive leukemia. Haematologica
  Sammendrag/abstract

2006

• Gruber, Franz; Hjorth-Hansen, H; Mikkola, ingvild; Stenke, L; Johansen, Terje. (2006) A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib. Leukemia
  Leserinnlegg
• Vanky, Eszter; Hjorth-Hansen, Henrik; Carlsen, Sven Magnus. (2006) Metformin and early pregnancy?. Fertility and Sterility
  Leserinnlegg
• Vanky, Eszter; Salvesen, Kjell Å; Hjorth-Hansen, Henrik; Bjerve, Kristian S; Carlsen, Sven Magnus. (2006) Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation. Fertility and Sterility
  Vitenskapelig artikkel
• Berentsen, Sigbjørn; Ulvestad, Tore Elling; Ulvestad, Elling; Langholm, Ruth; Beiske, Klaus; Hjorth-Hansen, Henrik. (2006) Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Studies in Surface Science and Catalysis
  Vitenskapelig artikkel

2005

• Rosti, Gianantonio; Martinelli, G; Castagnetti, F; Testoni, N; Specchia, G; Bassan, R. (2005) Imatinib 800 mg: Preliminary results of a phase II trial of the GIMEMA CML working party in intermediate sokal risk patients and status-of-the-art of an ongoing multinational, prospective randomized trial of imatinib standard dose (400 mg daily) vs high dose (800 mg daily) in high sokal risk patients. Blood
  Sammendrag/abstract
• Gruber, Franz; Lamark, T; Aanonli, T; Sovershaev, MA; Olsen, Marita; Gedde-dahl, Tobias. (2005) Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL. Leukemia
  Vitenskapelig artikkel
• Gruber, Franz; Lamark, Trond; Ånonli, Aileeen Cathrine; Sovershaev, Mikhail; Olsen, M; Gedde-Dahl, T. (2005) Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL. Leukemia
  Vitenskapelig artikkel

2004

• Hov, Håkon; Holt, Randi Utne; Rø, Torstein Baade; Fagerli, Unn-Merete; Hjort-Hansen, Henrik; Baykov, Vadim. (2004) A Selective c-Met Inhibitor Blocks an Autocrine Hepatocyte Growth Factor Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma cells. Clinical Cancer Research
  Vitenskapelig artikkel
• Holt, Randi Utne; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, ¯yvind; Sundan, Anders; Børset, Magne. (2004) Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene
  Vitenskapelig artikkel
• Hov, Håkon; Holt, Randi Utne; Rø, Torstein; Fagerli, Unn-merete; Hjorth-Hansen, Henrik; Baykov, Vadim. (2004) A selective c-Met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells. Clinical Cancer Research
  Vitenskapelig artikkel
• Standal, T; Hjort-Hansen, H; Rasmussen, T; Dahl, Inger Marie; Lenhoff, S; Brenne, AT. (2004) Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica
  Vitenskapelig artikkel
• Berentsen, Sigbjørn; Ulvestad, Elling; Gjertsen, Bjørn tore; Hjorth-Hansen, Henrik; Langholm, Ruth; Ghanima, Waleed. (2004) Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood
  Vitenskapelig artikkel
• Berentsen, S; Ulvestad, E; Gjertsen, BT; Hjort-Hansen, H; Langholm, R; Knutsen, H. (2004) Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood
  Vitenskapelig artikkel
• Standal, T; Hjorth-Hansen, Henrik; Rasmussen, T; Dahl, Inger Marie S.; Lenhoff, Stig; Brenne, Anne Tove. (2004) Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica
  Vitenskapelig artikkel
• Hjorth-Hansen, Henrik; Gruber, Franz; Gedde-dahl, Tobias. (2004) Nasjonalt handlingsprogram for kronisk myelogen leukemi. Norsk selskap for hematologi
  Rapport

2002

• Brenne, Anne Tove; Rø, Torstein Baade; Waage, Anders; Sundan, Anders; Børset, Magne; Hjorth-Hansen, Henrik. (2002) Interleukin-21 is a growth and survival factor for human myeloma cells. Blood
  Vitenskapelig artikkel

2001

• Hjorth-Hansen, Henrik. (2001) Sulter ut kreften med nye medisiner. Dagbladet
  Kronikk
• Seidel, Carina; Hjertner, ¯yvind; Abildgaard, Niels; Heikendorff, Lene; Hjorth, M.; Westin, Jan. (2001) Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood
  Vitenskapelig artikkel
• Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. (2001) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood
  Vitenskapelig artikkel
• Hjorth-Hansen, Henrik. (2001) Novel cytokines in growth control and bone disease of multiple myeloma. NTNU Trykk
  Doktorgradsavhandling

2000

• Hjertner, ¯yvind; Qvigstad, Gunnar; Hjorth-Hansen, Henrik; Seidel, Carina; Woodliff, Jeffery; Epstein, Joshua. (2000) Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells. British Journal of Haematology
  Vitenskapelig artikkel
• Seidel, Carina; Børset, Magne; Hjertner, ¯yvind; Cao, Dianjun; Abildgaard, Niels; Hjorth-Hansen, Henrik. (2000) High levels of soluble syndecan-1 in myeloma-derived bone marrow : modulation of hepatocyte growth factor activity. Blood
  Vitenskapelig artikkel

1999

• Hjorth-Hansen, Henrik; Seidel, Carina; Lamvik, Jon; Børset, Magne; Sundan, Anders; Waage, Anders. (1999) Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia. European Journal of Haematology
  Vitenskapelig artikkel
• Børset, Magne; Hjort-Hansen, Henrik; Johnsen, Ann-Charlotte; Seidel, Carina; Waage, Anders; Espevik, Terje. (1999) Apoptosis, proliferation and NF-k(kappa)B activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor. European Journal of Haematology
  Vitenskapelig artikkel
• Hjertner, ¯yvind; Torgersen, Maria Lyngaas; Seidel, Carina; Hjort-Hansen, Henrik; Waage, Anders; Børset, Magne. (1999) Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Sedretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease. Blood
  Vitenskapelig artikkel
• Børset, Magne; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders. (1999) The Role of Hepatocyte Growth Factor and its Receptor C-Met in Multiple Myeloma and Other Blood Malignancies. Leukemia and Lymphoma
  Vitenskapelig artikkel
• Hjort-Hansen, Henrik; Waage, Anders; Børset, M.. (1999) Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells. British Journal of Haematology
  Vitenskapelig artikkel
• Seidel, Carina; Hjorth-Hansen, Henrik; Bendz, Bjørn; Børset, Magne; Sandset, Per Morten; Hansen, John-Bjarne. (1999) Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals. British Journal of Haematology
  Vitenskapelig artikkel
• Hjorth-Hansen, Henrik; Seifert, Mark F.; Børset, Magne; Aarset, Harald; Østlie, Agnes; Sundan, Anders. (1999) Marked Osteoblastopenia and Reduced Bone Formation in a Model of Multiple Myeloma Bone Disease in Severe Combined Immunodeficiency Mice. Journal of Bone and Mineral Research
  Vitenskapelig artikkel
• Hjort-Hansen, Henrik; Seidel, Carina; Lamvik, Jon; Børset, Magne; Sundan, A.; Waage, Anders. (1999) Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia. European Journal of Haematology
  Vitenskapelig artikkel
• Hjertner, ¯yvind; Lyngaas Torgersen, Maria; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Børset, Magne. (1999) Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: A possible role for HGF in myeloma-associated osteolytic bone disease. Blood
  Vitenskapelig artikkel
• Børset, Magne; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders. (1999) The role of hepatocyte growth factor and its receptor C-Met in multiple myeloma and other blood malignancies. Leukemia and Lymphoma
  Vitenskapelig artikkel

1998

• Seidel, C; Børset, M; Hjort-Hansen, Henrik; Sundan, A; Waage, Anders. (1998) Role of hepatocyte growth factor and its receptor c-met in multiple myeloma. Medical Oncology (MO)
  Vitenskapelig artikkel

1996

• Børset, Magne; Hjorth-Hansen, Henrik; Seidel, Carina; Sundan, Anders; Waage, Anders. (1996) Hepatocyte growth factor and its receptor c-MET in multiple myeloma. Blood
  Vitenskapelig artikkel